These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5073304)

  • 1. Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 2. Inhibition of mammalian and oncogenic viral polymerases.
    Müller WE; Yamazaki ZI; Sögtrop HH; Zahn RK
    Eur J Cancer (1965); 1972 Aug; 8(4):421-8. PubMed ID: 5073304
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative inhibition of purified DNA polymerases from murine leukemia virus and human lymphocytes by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
    Schrecker AW; Smith RG; Gallo RC
    Cancer Res; 1974 Feb; 34(2):286-92. PubMed ID: 4129816
    [No Abstract]   [Full Text] [Related]  

  • 3. RNA-dependent DNA polymerase in viruses and cells: views on the current state.
    Gallo RC
    Blood; 1972 Jan; 39(1):117-37. PubMed ID: 4332948
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyridoxal 5' phosphate: a selective inhibitor of oncornaviral DNA polymerases.
    Modak MJ
    Biochem Biophys Res Commun; 1976 Jul; 71(1):180-7. PubMed ID: 183761
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA polymerases from RNA tumor viruses and human cells: inhibition by polyuridylic acid.
    Abrell JW; Smith RG; Robert MS; Gallo BC
    Science; 1972 Sep; 177(4054):1111-4. PubMed ID: 4115520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transciptase from Mason-Pfizer monkey tumor virus, avian myeloblastosis virus, and Rauscher leukemia virus and its response to rifamycin derivatives.
    Gallo RC; Abrell JW; Robert MS; Yang SS; Smith RG
    J Natl Cancer Inst; 1972 Apr; 48(4):1185-9. PubMed ID: 4336883
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleomycin, a selective inhibitor of DNA-dependent DNA polymerase from oncogenic RNA viruses.
    Müller WE; Yamazaki ZI; Zahn RK
    Biochem Biophys Res Commun; 1972 Feb; 46(4):1667-73. PubMed ID: 4111428
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oncogenic viruses and prospects for treatment of leukemia].
    Malec J
    Acta Haematol Pol; 1971; 2(4):281-4. PubMed ID: 4122078
    [No Abstract]   [Full Text] [Related]  

  • 9. Affinity chromatography of viral DNA polymerases on pyran-sepharose.
    Chirikjian JG; Rye L; Papas TS
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1142-6. PubMed ID: 165485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcriptase-progress, problems and prospects.
    O'Connor TE
    Bibl Haematol; 1973; 39():1165-81. PubMed ID: 4130390
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA polymerase activity associated with RNA tumor viruses.
    Hatanaka M; Huebner RJ; Gilden RV
    Proc Natl Acad Sci U S A; 1970 Sep; 67(1):143-7. PubMed ID: 4318773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RNA-directed DNA polymerase from Rauscher leukemia virus by the 5'-triphosphate of cytosine arabinoside.
    Tuominen FW; Kenney FT
    Biochem Biophys Res Commun; 1972 Sep; 48(6):1469-75. PubMed ID: 4116692
    [No Abstract]   [Full Text] [Related]  

  • 13. RNA tumor viruses, DNA polymerases, and oncogenesis: some selective effects of rifampicin derivatives.
    Gallo RC; Smith RG; Whang-Peng J; Ting RC; Yang SS; Abrell JW
    Medicine (Baltimore); 1972 May; 51(3):159-68. PubMed ID: 4336642
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of reverse transcriptase activity of RNA-tumor viruses by fagaronine+.
    Sethi VS; Sethi ML
    Biochem Biophys Res Commun; 1975 Apr; 63(4):1070-6. PubMed ID: 48379
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of biochemical characteristics of reverse transcriptase from human acute leukemic cells and several RNA tumor viruses.
    Sarin PS; Abrell JW; Gallo RC
    Basic Life Sci; 1974; 3():345-54. PubMed ID: 4132649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of some cytostatic agents on DNA-synthesis in an oncogenic RNA virus].
    Müller WE; Yamazaki Z; Forster W; Zahn RK
    Klin Wochenschr; 1972 Aug; 50(16):790-3. PubMed ID: 4116002
    [No Abstract]   [Full Text] [Related]  

  • 17. Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV.
    Ting RC; Yang SS; Gallo RC
    Nat New Biol; 1972 Apr; 236(67):163-6. PubMed ID: 4113337
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases by tilorone (NSC-143969) and its analogs.
    Schafer MP; Chirigos MA; Papas TS
    Cancer Chemother Rep; 1974; 58(6):821-27. PubMed ID: 4374997
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of DNA polymerases in oncornaviruses by modified nucleic acids.
    Chandra P
    Hamatol Bluttransfus; 1974; 14():216-23. PubMed ID: 4615045
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinogenesis: chemical and otherwise.
    Calvin M
    Radiat Res; 1972 Apr; 50(1):105-19. PubMed ID: 5063191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.